Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1998-05-22
2000-08-29
Park, Hankyel
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
530396, 536 234, C12P 2104, C07K 100, C07H 2104
Patent
active
061107085
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
The present invention relates to recombinant conglutinin having anti-virus activities (neutralization activities) which are expected to be applied to medicines and producing method thereof.
BACKGROUND ART
Conglutinin is an animal lectin belonged to calcium-dependent mammalian C-type lectin family and existed in the bovine serum. Whole amino acids sequence (SEQ ID No.:1) had been analyzed by Lee et al., [Lee et al., J. Biol. Chem., Vol. 266, pp. 2715-2723, 1991].
C-type lectin comprises basic unit having the four unique regions of (1) N-terminal region contained much cysteine, (2) collagen-like region, (3) neck region and (4) carbohydrate recognition domain (CRD) [Malhortra et al., European Journal Immunology, Vol. 22, pp. 1437-1445, 1992].
Besides conglutinin, C-type lectin includes Mannan-Binding Proteins (MBP), Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D), and they are generally called as collectin.
In vertebrates, mechanisms involving specific antibody reaction and immune response through the cells are considered as a main host-defense system against inversion of the pathogenic bacteria. However, recently, non-specific immune response by these lectins seems that it may play an important role to neutralize and remove the various microorganisms in the puerile subjects having the maternal transmigration antibody and the undeveloped specific defense system [Super et al., Lancet, Vol. 11, pp. 1236-1239, 1989].
Regarding the role of these lectins on biological defense in host organism, it is reported that infection will be easily spread by, for example, the reduction of the mannan-binding protein concentration in blood due to genetic mutation of the mannan-binding protein [Sumiya et al., Lancet, Vol. 337, pp. 1569-1570, 1991].
The present inventor once reported that the conglutinin and the mannan-binding protein inhibit infection and hemagglutination inhibition activity of H1 and H3 Type Influenza A Viruses (Wakamiya et al., Glycoconjugate J., Vol. 8, p. 235, 1991; Wakamiya et al., Biochem. Biophys. Res. Comm., Vol. 187, pp. 1270-1278, 1992).
Thereafter, the research group of the present inventor isolated cDNA clone encoding the conglutinin and found that there is the closer correlation between gene of the conglutinin and that from the various surfactant protein-D [Suzuki et al., Biochem. Biophys. Res. Comm., Vol. 191, pp. 335-342, 1993].
Accordingly, the conglutinin have been expected as useful material for physiologically active medicine component, but amount of the conglutinin to be obtained from the bovine serum is less. Further, continuous production of the conglutinin is quite difficult because source thereof is completely depended on an animal body. Expression of the conglutinin in Escherichia coli by the genetic recombinant techniques had been tried to realize the large scale production of the conglutinin.
In such process, first of all, whole cDNA of the conglutinin was amplified by PCR (Polymerase Chain Reaction) method, then the amplified genes were introduced into the expression vector pRSET-A and were expressed with M13/T7 phage. The recombinant conglutinin obtained was analyzed. Although expression of the recombinant conglutinin had been confirmed, expressed amounts are less to be barely detected by Western blotting. This approach is inconvenient to the large-scale production of the conglutinin.
Similar methods had also been tried by using another expression vectors, but the same or less expression level had merely detected by any of the vectors. Anyway, an effective expression system have not been realized yet in the art. This seems due to difficulties in expressing the conglutinin because Escherichia coli does not possess proteins of the structure like collagen-like region. Further, yield of the conglutinin produced from an eukaryotic cells is little, and some of the conglutinin may sometimes have an inappropriate post-transcriptional modification.
As stated above, although the conglutinin have been expected as an useful medicine component, neither the natural
REFERENCES:
Anders, E.M. et al., "Bovine and Mouse Serum .beta. Inhibitors of Influenza A Viruses Are Mannose-Binding Lectins," Proc. Natl. Acad. Sci. USA, 87(12):4485-4489 (Jun., 1990).
Eda, S. et al., Report No. 2002, "Expression of Recombinant Conglutinin in E. Coli," Seikagaku, 67(7):732 (Jul., 1995) (Japanese With English Translation).
Hartley, C.A. et al., "Two Distinct Serum Mannose-Binding Lectins Function as .beta. Inhibitors of Influenza Virus: Identification of Bovine Serum .beta. Inhibitor as Conglutinin," J. Virology, 66(7):4358-4363 (Jul., 1992).
Hoppe, H-J et al., "A Parallel Three Stranded .alpha.-helical Bundle at the Nucleation Site of Collagen Triple-Helix Formation," FEBS Letters, 344:191-195 (1994).
Kase, T. et al., Report No. 2006, "Study on Infection Inhibition Activities by Recombinant Conglutinin Against Influenza Viruses," Seikagaku, 67(7):732 (Jul., 1995). (Japanese With English Translation).
Kawasaki, N. et al., "Differentation of Conglutination Activity and Sugar-Binding Activity of Conglutinin After Removal of NH.sub.2 -Terminal 54 Amino Acid Residues by Endogenous Serine Protease(s)," Archives of Biochemistry and Biophysics, 305(2):533-540 (Sep., 1993).
Kawasaki, N. et al., "Gene Organization and 5'-Flanking Region Sequence of Conglutinin: A C-Type Mammalian Lectin Containing A Collagen-Like Domain," Biochemical Biophysical Research Communications, 198(2):597-604 (Jan. 28, 1994).
Lee, Y-M et al., "Primary Structure of Bovine Conglutinin, a Member of the C-type Animal Lectin Family," J. Biological Chemistry, 266(5):2715-2723 (Feb. 15, 1991).
Lim, B-L et al., "Expression of the Carbohydrate Recognition Domain of Bovine Conglutinin and Demonstration of Its Binding to iC3b and Yeast Mannan," Biochemical Biophysical Research Communications, 218(1):260-266 (1996).
Liou, L.S. et al., "Bovine Conglutinin (BC) mRNA Expressed in Liver: Cloning and Characterization of the BC cDNA Reveals Strong Homology to Surfactant Protein-D," Gene, 141(2):277-281 (1994).
Lu, J. et al., "Purification, Characterization and cDNA Cloning of Human Lung Surfactant Protein D," Biochem, J., 284:795-802 (1992).
Malhotra, R. et al., "Binding of Human Collectins (SP-A and MBP) to Influenza Virus," Biochem. J., 304(2):455-461 (1994).
Malhotra, R. et al., "Interaction of C1q Receptor With Lung Surfactant Protein A," Eur. J. Immunol., 22:1437-1445 (1992).
Nikkei Biotechnology, Article No. 4, p. 9 "Stable Expression of Recombinant Bkg Had Been Succeeded and Viral Inhibtion Activities Had Also Been Confirmed," (Sep. 25, 1995) (Japanese With English Translation).
Okuno, Y. et al., "Rapid Focus Reduction Neutralization Test of Influenza A and B Viruses in Microtiter System," J. Clinical Microbiology, 28(6):1308-1313 (Jun. 1990).
Reading, P.C. et al., "A Serum Mannose-Binding Lectin Mediates Complement-Dependent Lysis of Influenza Virus-Infected Cells," Biochemical and Biophysical Research Communications, 217(3):1128-1136 (Dec. 26, 1995).
Reading, P.C. et al., "A Serum Mannose-Binding Lectin Mediates Complement-Dependent Lysis of Influenza Virus-Infected Cells," J. Leukocyte Biology, 0(Suppl.): 45 (1993) (Abstract No. 72).
Sakamoto, T. et al., Report No. 2005, "Expression of Recombinant Human MBP in E. Coli," Seikagaku 67(7):732 (Jul., 1995). (Japanese With English Translation).
Sheriff, S. et al., "Human Mannose-Binding Protein Carbohydrate Recognition Domain Trimerizes Through a Triple .alpha.-helical Coiled-Coil.," Structural Biology, 1(11):789-794 (Nov., 1994).
Strang, C.J. et al., "Ultrastructure and Composition of Bovine Conglutinin," Biochem. J., 234:381-389 (1986).
Sumiya, M. et al., "Molecular Basis of Opsonic Defect in Immunodeficient Children," Lancet, 337:1569-1570 (Jun. 29, 1991).
Super, M. et al., "Association of Low Levels of Mannan-Binding Protein With a Common Defect of Opsonisation," Lancet, 2(8674):1236-1239 (Nov. 25, 1989).
Suzuki, Y. et al., "Cloning and Sequencing of a cDNA Coding for Bovine Conglutinin," Biochemical Biophysical Research Communica
Fuso Pharmaceutical Industries Ltd.
Park Hankyel
LandOfFree
Recombinant conglutinin and producing method thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant conglutinin and producing method thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant conglutinin and producing method thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248595